Publication | Closed Access

Effects of Three Months of Low Molecular Weight Heparin (dalteparin) Treatment After Bypass Surgery for Lower Limb Ischemia—A Randomised Placebo-controlled Double Blind Multicentre Trial

Lower Limb Ischemia—aCardiovascular DiseaseVascular SurgeryBypass SurgerySurgeryThree MonthsMedicineAnticoagulantIschemic SyndromeHeparinsAnesthesiology